Sectors
EDSA
Edesa Biotech, Inc.
5.35
1 x 4.91
1 x 7.02
bid
ask
+
0.11
2.10%
09:39 AM
timesize
| Ytd | 276.76% | |
| 1y | 153.55% |
5.31
day range
5.40
0.72
52 week range
20.32
| Open | 5.31 | Prev Close | 5.24 | Low | 5.31 | High | 5.40 | Mkt Cap | 51.54M |
| Vol | 934.00 | Avg Vol | 181.56K | EPS | -1.34 | P/E | -3.99 | Forward P/E | -0.89 |
| Beta | 1.08 | Short Ratio | 0.76 | Inst. Own | 12.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 6.36 | 200-d Avg | 5.00 | 1yr Est | 20.50 |
| Income Statement | |||
| Operating Expenses | 4.30M | ||
| Research and Development Expense | 2.77M | ||
| Selling, General and Administrative Expense | 1.53M | ||
| Operating Income | -4.30M | ||
| Income Tax Expense | 800.00 | ||
| Net Income | -4.22M | ||
| Net Income Common Stock | -4.22M | ||
| Net Income Common Stock (USD) | -4.22M | ||
| Consolidated Income | -4.22M | ||
| Earnings per Basic Share | -0.49 | ||
| Earnings per Basic Share (USD) | -0.49 | ||
| Earnings per Diluted Share | -0.49 | ||
| Earning Before Interest & Taxes (EBIT) | -4.22M | ||
| Earning Before Interest & Taxes (USD) | -4.22M | ||
| Weighted Average Shares | 8.54M | ||
| Weighted Average Shares Diluted | 8.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.00M | ||
| Cash and Equivalents (USD) | 10.00M | ||
| Investments | 39.92K | ||
| Investments Non-Current | 39.92K | ||
| Trade and Non-Trade Receivables | 216.47K | ||
| Current Assets | 10.42M | ||
| Total Assets | 12.38M | ||
| Current Liabilities | 2.19M | ||
| Total Liabilities | 2.19M | ||
| Accumulated Retained Earnings (Deficit) | -72.45M | ||
| Accumulated Other Comprehensive Income | -186.09K | ||
| Shareholders Equity | 10.20M | ||
| Shareholders Equity (USD) | 10.20M | ||
| Assets Non-Current | 1.97M | ||
| Goodwill and Intangible Assets | 1.93M | ||
| Trade and Non-Trade Payables | 2.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.87K | ||
| Net Cash Flow from Financing | -8.98K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.05M | ||
| Issuance (Purchase) of Equity Shares | -8.98K | ||
| Net Cash Flow from Operations | -2.02M | ||
| Effect of Exchange Rate Changes on Cash | -22.46K | ||
| Share Based Compensation | 484.85K | ||